Gary Curhan, MD, Chief Medical Officer, OM1, Brand Insights Contributor
Advertisement
Articles by Gary Curhan, MD, Chief Medical Officer, OM1, Brand Insights Contributor
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Oral Weight Loss Pill Prescribed Over 1,000 Times in First Days on Market
2
Eli Lilly Releases Updated Safety Data for Foundayo Following FDA’s Request
3
Positioning A New Standard of Care in Relapsed Multiple Myeloma: Q&A with Imran Khan, MD, PhD
4
The Turning Point for Oral Biologics: Q&A With Morten Graugaard
5